JP2010513334A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513334A5
JP2010513334A5 JP2009541766A JP2009541766A JP2010513334A5 JP 2010513334 A5 JP2010513334 A5 JP 2010513334A5 JP 2009541766 A JP2009541766 A JP 2009541766A JP 2009541766 A JP2009541766 A JP 2009541766A JP 2010513334 A5 JP2010513334 A5 JP 2010513334A5
Authority
JP
Japan
Prior art keywords
compound
pyridin
dichloro
dimethoxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009541766A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010513334A (ja
JP5342451B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2007/000564 external-priority patent/WO2008077404A1/en
Publication of JP2010513334A publication Critical patent/JP2010513334A/ja
Publication of JP2010513334A5 publication Critical patent/JP2010513334A5/ja
Application granted granted Critical
Publication of JP5342451B2 publication Critical patent/JP5342451B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009541766A 2006-12-22 2007-12-21 Pde4阻害剤として有用な置換アセトフェノン Expired - Fee Related JP5342451B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87168906P 2006-12-22 2006-12-22
US60/871,689 2006-12-22
US94547007P 2007-06-21 2007-06-21
US60/945,470 2007-06-21
PCT/DK2007/000564 WO2008077404A1 (en) 2006-12-22 2007-12-21 Substituted acetophenones useful as pde4 inhibitors

Publications (3)

Publication Number Publication Date
JP2010513334A JP2010513334A (ja) 2010-04-30
JP2010513334A5 true JP2010513334A5 (https=) 2013-08-22
JP5342451B2 JP5342451B2 (ja) 2013-11-13

Family

ID=39156588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541766A Expired - Fee Related JP5342451B2 (ja) 2006-12-22 2007-12-21 Pde4阻害剤として有用な置換アセトフェノン

Country Status (23)

Country Link
US (3) US8148537B2 (https=)
EP (1) EP2125736B1 (https=)
JP (1) JP5342451B2 (https=)
KR (1) KR101507717B1 (https=)
AT (1) ATE503742T1 (https=)
AU (1) AU2007336538B2 (https=)
BR (1) BRPI0721113A2 (https=)
CA (1) CA2673370C (https=)
CR (1) CR10877A (https=)
CY (1) CY1111596T1 (https=)
DE (1) DE602007013617D1 (https=)
DK (1) DK2125736T3 (https=)
GT (1) GT200900172A (https=)
HR (1) HRP20110464T1 (https=)
IL (1) IL199383A (https=)
MX (1) MX2009006593A (https=)
MY (1) MY146022A (https=)
NO (1) NO20092372L (https=)
NZ (1) NZ577863A (https=)
PL (1) PL2125736T3 (https=)
PT (1) PT2125736E (https=)
RU (1) RU2493149C2 (https=)
WO (1) WO2008077404A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ601001A (en) 2009-12-22 2014-07-25 Leo Pharma As Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
BR112012015433B8 (pt) 2009-12-22 2020-03-03 Leo Pharma As composição farmacêutica substancialmente anidra para aplicação cutânea
MX2012007234A (es) 2009-12-22 2012-07-30 Leo Pharma As Nanocristales de monohidrato de calciprotiol.
CN102775345A (zh) * 2011-05-13 2012-11-14 上海特化医药科技有限公司 制备罗氟司特的方法及中间体
EP2925364A1 (en) * 2012-11-30 2015-10-07 Leo Pharma A/S A method of inhibiting the expression of il-22 in activated t-cells
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
SI3060551T1 (sl) * 2013-10-22 2019-11-29 Chiesi Farm Spa Postopek za pripravo inhibitorja PDE4
MX2016016378A (es) * 2014-06-23 2017-10-16 Leo Pharma As Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
DK3390407T3 (da) 2015-12-18 2023-11-06 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
KR101702648B1 (ko) * 2016-05-10 2017-02-03 주식회사 엑티브온 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물
DK3642210T3 (da) 2017-06-20 2024-12-09 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
EP3838967A1 (en) * 2019-12-16 2021-06-23 Spago Nanomedical AB Immobilization of phenolic compounds
CN117924243B (zh) * 2024-01-16 2025-09-12 沈阳药科大学 一种喹啉衍生物及其药用组合物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (https=) * 1992-12-23 1995-11-21 Celltech Ltd
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
WO1998022455A1 (en) * 1996-11-19 1998-05-28 Kyowa Hakko Kogyo Co., Ltd. Oxygenic heterocyclic compounds
MXPA05009921A (es) * 2003-03-17 2005-11-04 Kyowa Hakko Kogyo Kk Agentes terapeuticos y/o preventivos para enfermedades cutaneas cronicas.
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors

Similar Documents

Publication Publication Date Title
JP2010513334A5 (https=)
HRP20110464T1 (hr) Supstituirani acetofenoni korisni kao inhibitori pde4
RU2461551C2 (ru) Азолкарбоксамидное соединение или его фармацевтически приемлемая соль
JP2013542220A5 (ja) Crac調節剤としてのオキサゾリン及びイソキサゾリン誘導体
RU2013103538A (ru) 1-гидроксиимино-3-фенил-пропаны
RU2009116670A (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
JP2006518763A5 (https=)
RU2001126559A (ru) Активаторы глюкокиназы
JP2010540462A5 (https=)
RU2010119648A (ru) Пиразолы как 11-бета-hsd-1
RU2312105C2 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
CN101622231A (zh) 作为葡糖激酶激活剂的2,2,2-三取代的乙酰胺衍生物、它们的制造方法和药学应用
JP2004532227A5 (https=)
CA2648569A1 (en) Pyridyl amide t-type calcium channel antagonists
JP2004529931A5 (https=)
RU2015113746A (ru) Замещенные сульфонамиды
RU2005119627A (ru) Ингибиторы фосфодиэстеразы 4
RU2013145418A (ru) Циклоалкениларильные производные для ингибирования транспортного белка холестериновых эфиров
JP2008527042A5 (https=)
HRP20161702T1 (hr) Novi derivati pirazina
JP2018521021A5 (https=)
CA2594684A1 (en) Morpholines as 5ht2c agonists
JP2019521153A5 (https=)
JPWO2023085396A5 (https=)
RU2010148901A (ru) Новые производные пиридина в качестве миметиков модуляторов лептинового рецептора